Skip to content

Management of Type 2 Diabetes Mellitus through Ayurveda

A Two Arm, Randomized, controlled, double blinded Study on Ayurvedic management of Type-2 Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018336
Enrollment
300
Registered
2019-03-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Ayurveda Drug: AYUSH-82 extract tablet, 4 tablets per day (2 in the morning, 2 at night), for a period of 6 months Control Intervention1: Placebo: Placebo capsules, 4 tablets per day (2

Sponsors

Jivanti Welfare and Charitable Trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Known / diagnosed Type-2 diabetics picked up from screened population with >60 score on IDRS 2. without hypertension and obesity 3. Those on oral hypo glycemic drugs [any OHA] 4. Subjects with HbA1C � 6.4%

Exclusion criteria

Exclusion criteria: 1. Morbid Obesity [BMI � 40 kg/m2] 2. Subjects with conditions such as uncontrolled hypertension (persistent BP > 180/ 100 mm of Hg after two consecutive recordings and also by checking from their earlier medical records) or severe range of obesity [BMI � 40 kg/m2] 3. History of a major/ minor surgery in the past 3 months. 4. History of tuberculosis within past 3 years. 5. History of head injury, neurological or psychiatric disorder in the past 6. Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
HbA1c Fasting Blood SugarTimepoint: Baseline 3 months 6 months

Secondary

MeasureTime frame
Lipid Profile (LDL, HDL, VLDL, TC, TG) Liver Function (SGOT, SGPT) Kidney function(Urea, Creatinine, Uric Acid Timepoint: Baseline 3 months 6 months

Countries

India

Contacts

Public ContactDr Amit Singh

Vivekananda Yoga Anusandhana Samsthana

rnagaratna@gmail.com08022639953

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026